⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11518900 | 0.96 | — | — | |
| SCHEMBL11293193 | 0.76 | — | — | |
| SCHEMBL3417754 | 0.73 | CA5A (0.31) | — | |
| SCHEMBL31506896 | 0.73 | — | — | |
| SCHEMBL21646117 | 0.73 | — | — | |
| SCHEMBL9400119 | 0.73 | CA5A (0.31) | — | |
| SCHEMBL2046056 | 0.73 | — | — | |
| SCHEMBL11129190 | 0.72 | — | — | |
| SCHEMBL3620813 | 0.70 | — | — | |
| SCHEMBL5155872 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034088-A1 | SULFOPROPANOIC ACID DERIVATIVES FOR TREATING NEURODEGENERATIVE DISORDERS | ALZHEON INC (US) | 2026-02-05 | — | — | US | disclosed |
| EP-4296670-B1 | SULFOPROPANOIC ACID DERIVATIVES FOR TREATING NEURODEGENERATIVE DISORDERS | ALZHEON INC (US) | 2025-11-26 | — | — | EP | disclosed |
| US-12285400-B2 | Sulfopropanoic acid derivatives for treating neurodegenerative disorders | ALZHEON, INC. (US) | 2025-04-29 | — | — | US | disclosed |
| CN-114206884-B | Thienopyrimidine derivatives as ACC inhibitors and use thereof | 吉利德科学公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-117865911-A | Preparation method of 3-methyl-1, 2, 4-thiadiazole-5-carbohydrazide | 成都科圣原医药科技有限公司 | 2024-04-12 | — | — | CN | disclosed |
| EP-4296670-A2 | SULFOPROPANOIC ACID DERIVATIVES FOR TREATING NEURODEGENERATIVE DISORDERS | Alzheon, Inc. (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-3829568-B1 | SULFOPROPANOIC ACID DERIVATIVES FOR TREATING NEURODEGENERATIVE DISORDERS | ALZHEON INC (US) | 2023-09-06 | — | — | EP | disclosed |
| CN-113248481-B | EZH2 covalent irreversible inhibitor, preparation method and application thereof | 中山大学 | 2023-03-24 | — | — | CN | disclosed |
| CN-111212838-B | Deuterated Finanentane | 欧歌达有限公司 | 2022-12-02 | — | — | CN | disclosed |
| US-20220087967-A1 | SULFOPROPANOIC ACID DERIVATIVES FOR TREATING NEURODEGENERATIVE DISORDERS | ALZHEON, INC. | 2022-03-24 | — | — | US | disclosed |
| US-20070105864-A1 | Methods for inhibiting protein kinases | SCHERING CORPORATION | 2007-05-10 | — | — | US | disclosed |
| US-20060106023-A1 | Novel imidazopyrazines as cyclin dependent kinase inhibitors | SCHERING CORPORATION | 2006-05-18 | — | — | US | disclosed |
| US-5264586-A | Antibiotics, antitumor, chemical intermediates | THE SCRIPPS RESEARCH INSTITUTE (US) | 1993-11-23 | — | — | US | disclosed |
| WO-1993010086-A1 | PROCESS FOR PREPARING N-(ARYLSULPHONYL)-CARBAMIDE ACID DERIVATES AND INTERMEDIATES USEFUL FOR CARRYING OUT THIS PROCESS | MTA Központi Kémiai Kutató Intézete (HU) | 1993-05-27 | — | — | WO | disclosed |
| WO-1993001810-A1 | ANALOGS OF CALICHEAMICIN η1I, METHOD OF MAKING AND USING THE SAME | THE SCRIPPS RESEARCH INSTITUTE (US) | 1993-02-04 | — | — | WO | disclosed |
| EP-0279239-B1 | MICROBICIDES | CIBA-GEIGY AG (CH) | 1992-11-11 | — | — | EP | disclosed |
| US-5135927-A | 2-chloro-4-trifluoromethylthiazol-5-carboxylic acid | CIBA-GEIGY CORPORATION (US) | 1992-08-04 | — | — | US | disclosed |
| US-4992434-A | Prevention of infestation of plants by phytopathogenic microorganisms | CIBA-GEIGY CORPORATION (US) | 1991-02-12 | — | — | US | disclosed |
| EP-0279239-A1 | Microbicides | CIBA-GEIGY AG (CH) | 1988-08-24 | — | — | EP | disclosed |
| US-4261728-A | PREEMERGENT ACTIVITY | MONSANTO COMPANY (US) | 1981-04-14 | — | — | US | disclosed |